Glucosamine



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 27.2%
Drug Use For Unknown Indication 10.3%
Blood Cholesterol Increased 5.9%
Depression 5.9%
Convulsion 4.4%
Sinus Disorder 4.4%
Supplementation Therapy 4.4%
Ankylosing Spondylitis 3.7%
Arthralgia 3.7%
Gastrooesophageal Reflux Disease 3.7%
Pain 3.7%
Routine Health Maintenance 3.7%
Neuralgia 2.9%
Sciatica 2.9%
Arthritis 2.2%
Bronchitis 2.2%
Hypertension 2.2%
Osteoarthritis 2.2%
Osteoporosis 2.2%
Spinal Column Stenosis 2.2%
Dyspnoea 11.8%
Drug Interaction 8.8%
Rash 8.8%
Completed Suicide 5.9%
Liver Disorder 5.9%
Nausea 5.9%
Pain In Extremity 5.9%
Tremor 5.9%
Vomiting 5.9%
Weight Decreased 5.9%
Chondropathy 2.9%
Coombs Direct Test Positive 2.9%
Creutzfeldt-jakob Disease 2.9%
Death 2.9%
Drug Hypersensitivity 2.9%
Drug Ineffective 2.9%
Feeling Abnormal 2.9%
Gamma-glutamyltransferase Increased 2.9%
Headache 2.9%
Hepatitis Acute 2.9%
Concomitant
Product Used For Unknown Indication 28.6%
Drug Use For Unknown Indication 25.9%
Hypertension 6.2%
Rheumatoid Arthritis 5.5%
Osteoporosis 4.0%
Arthritis 3.1%
Pain 3.0%
Blood Cholesterol Increased 2.6%
Supplementation Therapy 2.5%
Prophylaxis 2.4%
Vitamin Supplementation 2.0%
Arthralgia 2.0%
Atrial Fibrillation 1.8%
Osteoarthritis 1.7%
Depression 1.6%
Gastrooesophageal Reflux Disease 1.6%
Breast Cancer 1.4%
Asthma 1.4%
Diabetes Mellitus 1.4%
Multiple Myeloma 1.2%
Weight Decreased 9.8%
Vomiting 9.3%
Flushing 8.2%
Weight Increased 7.6%
Drug Ineffective 6.2%
Pruritus 5.6%
Pain 5.0%
Vision Blurred 4.6%
Pain In Extremity 4.5%
Pulmonary Embolism 4.2%
Nausea 4.1%
Myocardial Infarction 4.0%
Rash 4.0%
Urinary Tract Infection 4.0%
Urticaria 3.8%
Pyrexia 3.7%
Fatigue 3.2%
Diarrhoea 2.9%
Tremor 2.9%
Pneumonia 2.7%
Interacting
Product Used For Unknown Indication 46.2%
Carpal Tunnel Syndrome 15.4%
Anticoagulant Therapy 7.7%
Gastrooesophageal Reflux Disease 7.7%
Hypercholesterolaemia 7.7%
Hypertension 7.7%
Smoking Cessation Therapy 7.7%
Drug Ineffective 28.6%
Drug Interaction 28.6%
International Normalised Ratio Increased 14.3%
Pain 14.3%
Paraesthesia 14.3%